Rüdt Matthias, Brestrich Nina, Rolinger Laura, Hubbuch Jürgen
Karlsruhe Institute of Technology, Karlsruhe, Germany.
Biotechnol Bioeng. 2017 Feb;114(2):368-373. doi: 10.1002/bit.26078. Epub 2016 Sep 21.
The load phase in preparative Protein A capture steps is commonly not controlled in real-time. The load volume is generally based on an offline quantification of the monoclonal antibody (mAb) prior to loading and on a conservative column capacity determined by resin-life time studies. While this results in a reduced productivity in batch mode, the bottleneck of suitable real-time analytics has to be overcome in order to enable continuous mAb purification. In this study, Partial Least Squares Regression (PLS) modeling on UV/Vis absorption spectra was applied to quantify mAb in the effluent of a Protein A capture step during the load phase. A PLS model based on several breakthrough curves with variable mAb titers in the HCCF was successfully calibrated. The PLS model predicted the mAb concentrations in the effluent of a validation experiment with a root mean square error (RMSE) of 0.06 mg/mL. The information was applied to automatically terminate the load phase, when a product breakthrough of 1.5 mg/mL was reached. In a second part of the study, the sensitivity of the method was further increased by only considering small mAb concentrations in the calibration and by subtracting an impurity background signal. The resulting PLS model exhibited a RMSE of prediction of 0.01 mg/mL and was successfully applied to terminate the load phase, when a product breakthrough of 0.15 mg/mL was achieved. The proposed method has hence potential for the real-time monitoring and control of capture steps at large scale production. This might enhance the resin capacity utilization, eliminate time-consuming offline analytics, and contribute to the realization of continuous processing. Biotechnol. Bioeng. 2017;114: 368-373. © 2016 The Authors. Biotechnology and Bioengineering published by Wiley Periodicals, Inc.
在制备性蛋白A捕获步骤中的上样阶段,通常无法进行实时控制。上样体积一般基于上样前单克隆抗体(mAb)的离线定量分析以及通过树脂寿命研究确定的保守柱容量。虽然这会导致批次模式下的生产率降低,但为了实现单克隆抗体的连续纯化,必须克服合适的实时分析这一瓶颈。在本研究中,采用基于紫外/可见吸收光谱的偏最小二乘回归(PLS)建模来定量蛋白A捕获步骤上样阶段流出物中的mAb。基于HCCF中具有可变mAb滴度的几条穿透曲线成功校准了一个PLS模型。该PLS模型预测验证实验流出物中的mAb浓度,均方根误差(RMSE)为0.06 mg/mL。当产品突破达到1.5 mg/mL时,该信息被用于自动终止上样阶段。在研究的第二部分,通过在校准中仅考虑低mAb浓度并减去杂质背景信号,进一步提高了该方法的灵敏度。所得PLS模型的预测RMSE为0.01 mg/mL,并且当产品突破达到0.15 mg/mL时,成功用于终止上样阶段。因此,所提出的方法具有在大规模生产中实时监测和控制捕获步骤的潜力。这可能会提高树脂容量利用率,消除耗时的离线分析,并有助于实现连续加工。《生物技术与生物工程》2017年;114: 368 - 373。© 2016作者。由Wiley Periodicals, Inc.出版的《生物技术与生物工程》